Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights
A Covid-19 vaccine developed by the French company Valneva has received the green light from…
20/04/2022 - 4 minutes
Covid-19: Updates on Research, Vaccines, and Treatments
The Covid-19 pandemic began as a few scattered cases in China, but within months, the respiratory infection had swept the world. The years 2020 and 2021 turned into a rollercoaster ride for the world’s population, with millions of people dead, livelihoods destroyed, and movement between countries plummeting.
Despite the strained situation, academic researchers and biotech and pharma companies globally have come together to develop protective vaccines and treatments against Covid-19. While we still have a long road ahead before this pandemic is declared over, the life sciences industry is bringing us closer to this moment with every new discovery, trial result, and fundraise. Read on to learn about the latest research, investments, trends, and pipeline developments.
Show More
Editor's Picks for Covid-19
- Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines
- Vaccine Biotechs Gear Up to Take On Covid-19 Variants
- Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
- Tracking Covid-19 Cases with Wastewater Testing
- Developing a Vaccine that Protects Against Covid-19 Variants
European Biotech Industry Report 2021: A Year of European Biotechnology
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations in the biotech and pharma industry.
Go to ReportLatest Covid-19 Articles
WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics
The World Health Organization has released a 10-year plan to monitor the genetic make-up of…
05/04/2022 - 4 minutes
Europe Shuns Russian Covid-19 Vaccines as Ukraine War Continues
In the last two years, Russian Covid-19 vaccine makers had a tough time penetrating the…
01/04/2022 - 3 minutes
Sponsored
by Merck
How a Global Network Accelerated the Development of a Virus-Like Particle Vaccine Against Covid-19
Vaccines are among the most effective ways to improve and protect human health. Whereas vaccines…
22/02/2022 - 5 minutes
Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to…
15/02/2022 - 7 minutes
Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA
Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M…
01/02/2022 - 3 minutes
The Biggest European Biotech News of 2021
In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has…
22/12/2021 - 10 minutes
Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines
The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with…
25/11/2021 - 6 minutes
Vaccine Biotechs Gear Up to Take On Covid-19 Variants
Vaccines for Covid-19 are rolling out all over the world, but their protection is threatened…
15/11/2021 - 7 minutes
Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…
26/10/2021 - 5 minutes
Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
13/09/2021 - 10 minutes
Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology
Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are…
17/08/2021 - 5 minutes
